Kosuke Matsui
About
Kosuke Matsui is a scholar working on Hepatology, Surgery and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Kosuke Matsui has authored 154 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Hepatology, 51 papers in Surgery and 35 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kosuke Matsui's work include Hepatocellular Carcinoma Treatment and Prognosis (48 papers), Liver Disease Diagnosis and Treatment (24 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers). Kosuke Matsui is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (48 papers), Liver Disease Diagnosis and Treatment (24 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers). Kosuke Matsui collaborates with scholars based in Japan, United States and Vietnam. Kosuke Matsui's co-authors include Shizuo Akira, Osamu Takeuchi, Hiroki Kato, Satoshi Uematsu, Shintaro Sato, Masahiro Yamamoto, Taro Kawai, Takashi Fujita, Mitsutoshi Yoneyama and Tohru Tsujimura and has published in prestigious journals such as Nature, Journal of Biological Chemistry and The Journal of Experimental Medicine.
In The Last Decade
Kosuke Matsui
141 papers receiving 8.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Kosuke Matsui Japan | 33 | 4.7k | 2.3k | 1.8k | 1.4k | 1.0k | 154 | 8.5k | ||
| Etienne Meylan Switzerland | 31 | 5.3k 1.1× | 3.7k 1.6× | 1.3k 0.7× | 1.4k 1.0× | 1.8k 1.7× | 43 | 8.5k | ||
| JF Schlaak Germany | 48 | 2.7k 0.6× | 1.4k 0.6× | 3.2k 1.8× | 966 0.7× | 660 0.6× | 172 | 7.8k | ||
| Gail A. Bishop United States | 54 | 7.3k 1.6× | 3.3k 1.5× | 1.5k 0.8× | 2.0k 1.5× | 2.5k 2.4× | 217 | 11.7k | ||
| Yoshiyuki Niho Japan | 49 | 2.9k 0.6× | 2.4k 1.0× | 1.3k 0.7× | 1.9k 1.4× | 448 0.4× | 423 | 9.2k | ||
| Vito Racanelli Italy | 47 | 2.0k 0.4× | 1.7k 0.7× | 1.4k 0.8× | 1.6k 1.1× | 513 0.5× | 151 | 6.5k | ||
| Richard H. Duerr United States | 34 | 3.2k 0.7× | 2.0k 0.9× | 2.3k 1.3× | 609 0.4× | 554 0.5× | 81 | 8.0k | ||
| Matteo Iannacone Italy | 36 | 3.2k 0.7× | 1.4k 0.6× | 1.5k 0.9× | 1.1k 0.8× | 301 0.3× | 98 | 6.2k | ||
| Weisan Chen Australia | 52 | 5.4k 1.2× | 3.6k 1.6× | 2.0k 1.1× | 2.1k 1.5× | 822 0.8× | 181 | 8.9k | ||
| Anthony Meager United Kingdom | 53 | 3.5k 0.7× | 1.6k 0.7× | 1.2k 0.7× | 917 0.7× | 330 0.3× | 167 | 8.1k | ||
| Brian L. Kotzin United States | 59 | 8.5k 1.8× | 1.7k 0.8× | 1.3k 0.7× | 1.4k 1.0× | 270 0.3× | 175 | 13.5k |
Countries citing papers authored by Kosuke Matsui
Since
Specialization
Citations
This map shows the geographic impact of Kosuke Matsui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kosuke Matsui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kosuke Matsui more than expected).
Fields of papers citing papers by Kosuke Matsui
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Kosuke Matsui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kosuke Matsui. The network helps show where Kosuke Matsui may publish in the future.
Co-authorship network of co-authors of Kosuke Matsui
This figure shows the co-authorship network connecting the top 25 collaborators of Kosuke Matsui. A scholar is included among the top collaborators of Kosuke Matsui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kosuke Matsui. Kosuke Matsui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Matsui, Kosuke, Hideyuki Matsushima, Hidekazu Yamamoto, et al.. (2025). Efficacy of Sequential Hepatic Vein Embolization Following Portal Vein Embolization in Promoting Regeneration of Liver Volume and Function Before Right‐Sided Major Hepatectomy. Annals of Gastroenterological Surgery. 10(1). 229–240.
2.
Matsui, Kosuke, Hisashi Kosaka, Hideyuki Matsushima, et al.. (2025). Cachexia Index as a Prognostic Indicator in Patients with Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy. Oncology. 104(2). 113–124.
3.
Yoshimura, Ryuichi, et al.. (2025). Dysphagia and the prevalence of chronic kidney disease: a cross-sectional study. International Urology and Nephrology. 58(3). 981–987.
4.
Yamaguchi, Tomohiro, Hisashi Kosaka, Katsunori Yoshida, et al.. (2024). Efficacy of lenvatinib and transarterial chemoembolization combination therapy in patients with hepatocellular carcinoma administered an insufficient dose of early lenvatinib. Molecular and Clinical Oncology. 21(3). 63–63.
5.
Kaibori, Masaki, Kengo Yoshii, Kosuke Matsui, et al.. (2023). The Prognostic Impact of ABO Blood Group in Hepatocellular Carcinoma Following Hepatectomy. Cancers. 15(11). 2905–2905.
6.
Kaibori, Masaki, Atsushi Hiraoka, Hiroya Iida, et al.. (2022). Comparison of the New Neo-Glasgow Prognostic Score Based on the Albumin-Bilirubin Grade with Currently Used Nutritional Indices for Prognostic Prediction following Surgical Resection of Hepatocellular Carcinoma: A Multicenter Retrospective Study in Japan. Cancers. 14(9). 2091–2091.
7.
Kaibori, Masaki, Hisashi Kosaka, Kosuke Matsui, et al.. (2022). Efficacy of Nanofiber Sheets Incorporating Lenvatinib in a Hepatocellular Carcinoma Xenograft Model. Nanomaterials. 12(8). 1364–1364.
8.
Kaibori, Masaki, Kengo Yoshii, Hisashi Kosaka, et al.. (2022). Preoperative Serum Markers and Risk Classification in Intrahepatic Cholangiocarcinoma: A Multicenter Retrospective Study. Cancers. 14(21). 5459–5459.
9.
Kaibori, Masaki, Atsushi Hiraoka, Kosuke Matsui, et al.. (2022). Predicting Complications following Surgical Resection of Hepatocellular Carcinoma Using Newly Developed Neo-Glasgow Prognostic Score with ALBI Grade: Comparison of Open and Laparoscopic Surgery Cases. Cancers. 14(6). 1402–1402.
10.
Kaibori, Masaki, Kengo Yoshii, Kosuke Matsui, et al.. (2022). Modified Albumin-Bilirubin Grade and Alpha-Fetoprotein Score (mALF Score) for Predicting the Prognosis of Hepatocellular Carcinoma after Hepatectomy. Cancers. 14(21). 5292–5292.
11.
Kaibori, Masaki, Hideyuki Matsushima, Morihiko Ishizaki, et al.. (2021). Perioperative Geriatric Assessment as A Predictor of Long-Term Hepatectomy Outcomes in Elderly Patients with Hepatocellular Carcinoma. Cancers. 13(4). 842–842.
12.
Kaibori, Masaki, Kosuke Matsui, Mitsuo Shimada, Shoji Kubo, & Kiyoshi Hasegawa. (2021). Update on perioperative management of patients undergoing surgery for liver cancer. Annals of Gastroenterological Surgery. 6(3). 344–354.
13.
Ishizaki, Morihiko, Masaki Kaibori, Hideyuki Matsushima, et al.. (2021). Long-term complete response to lenvatinib in a patient with unresectable hepatocellular carcinoma. Clinical Journal of Gastroenterology. 14(6). 1700–1705.
14.
Kaibori, Masaki, Hiroya Iida, Kosuke Matsui, et al.. (2015). [OBJECTIVE ASSESSMENT OF POSTOPERATIVE PAIN AFTER DIGESTIVE TRACT SURGERY].. PubMed. 116(4). 243–8.
15.
Kaibori, Masaki, et al.. (2013). Sorafenib alone versus a combination of sorafenib and ninjin'yoeito for the treatment of patients with advanced hepatocellular carcinoma: a retrospective study and pharmacological study in rats. 30(5). 221–228.
16.
Kaibori, Masaki, Kosuke Matsui, Morihiko Ishizaki, et al.. (2013). Hepatic Resection for Hepatocellular Carcinoma in the Elderly. Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons). 38(2). 224–231.
17.
Sakaguchi, Tatsuma, Masaki Kaibori, Morihiko Ishizaki, et al.. (2012). A case of hepatic angiomyolipoma showing high 18f-fluorodeoxyglucose uptake on positron emission tomography. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 73(4). 947–951.
18.
Kaibori, Masaki, et al.. (2008). Resection of Metastatic Liver Cancer in a Jehovah's Witness Patient: A Case Report. The Japanese Journal of Gastroenterological Surgery. 41(8). 1655–1660.
19.
Kaibori, Masaki, Sang Kil Ha‐Kawa, Yoichiro Uchida, et al.. (2007). Liver Regeneration in Donors Evaluated by Tc-99m-GSA Scintigraphy after Living Donor Liver Transplantation. Digestive Diseases and Sciences. 53(3). 850–855.
20.
Mayumi, Hisanori, et al.. (1992). [Effects of open-heart surgery on renal function in patients with chronic renal failure--is hemodialysis during cardiopulmonary bypass really required?].. PubMed. 40(10). 1839–46.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Etienne Meylan Breakdown of academic impact, for papers by JF Schlaak Breakdown of academic impact, for papers by Gail A. Bishop Breakdown of academic impact, for papers by Yoshiyuki Niho Breakdown of academic impact, for papers by Vito Racanelli Breakdown of academic impact, for papers by Richard H. Duerr Breakdown of academic impact, for papers by Matteo Iannacone Breakdown of academic impact, for papers by Weisan Chen Breakdown of academic impact, for papers by Anthony Meager Breakdown of academic impact, for papers by Brian L. Kotzin